资讯
Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...
CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
3 天
News-Medical.Net on MSNBoosting CAR T cell survival to improve solid tumor therapyMarcela Maus, MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass ...
Marcela Maus , MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O'Keeffe Endowed Chair of the Mass ...
6 天
AZoNano on MSNOptimizing Antigen Density on Gold Nanoparticles for Cancer VaccinesA study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...
15 小时
ZME Science on MSNCAR T Breakthrough Therapy Doubles Survival Time for Deadly Stomach CancerThe cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...
6 天
News-Medical.Net on MSNEva1 targeted CAR T cells successfully eliminate tumors in preclinical studyCAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
Two brothers and prostate cancer patients from Shrewsbury joined a UK-wide movement to say "you don’t need a finger up the ...
To assess T-cell-induced morphological changes, each organoid was segmented in the transmitted light (TL) channel using a ...
For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...
The firm is developing the PHOX2B-targeted cell therapy, which has shown promise in preclinical xenograft models, with CHOP researchers.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果